FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’
Global News
WASHINGTON (AP) — The head of the Food and Drug Administration's drug center abruptly resigned Sunday after federal officials began reviewing "serious concerns about his personal conduct," according to a government spokesperson.
WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according to a government spokesperson.
Dr. George Tidmarsh, who was named to the FDA post in July, was placed on leave Friday after officials in the Department of Health and Human Services’ Office of General Counsel were notified of the issues, HHS press secretary Emily Hilliard said in an email. Tidmarsh then resigned Sunday morning.
“Secretary Kennedy expects the highest ethical standards from all individuals serving under his leadership and remains committed to full transparency,” Hilliard said.
The departure came the same day that a drugmaker connected to one of Tidmarsh’s former business associates filed a lawsuit alleging that he made “false and defamatory statements,” during his time at the FDA.
The lawsuit, brought by Aurinia Pharmaceuticals, alleges that Tidmarsh used his FDA position to pursue a “longstanding personal vendetta” against the chair of the company’s board of directors, Kevin Tang.
Tang previously served as a board member of several drugmakers where Tidmarsh was an executive, including La Jolla Pharmaceutical, and was involved in his ouster from those leadership positions, according to the lawsuit.
Messages placed to Tidmarsh and his lawyer were not immediately returned late Sunday.
Tidmarsh founded and led a series of pharmaceutical companies over several decades working in California’s pharmaceutical and biotech industries. Before joining the FDA, he also served as an adjunct professor at Stanford University. He was recruited to join the agency over the summer after meeting with FDA Commissioner Marty Makary.
Edmonton's single-use waste rules were controversial and unpopular when introduced in 2023 — but new data shows the changes are having the intended effect of reducing garbage.
Carney's speech to Australia's parliament highlighted a soon-to-launch Canadian low earth orbit satellite network that experts say could soon compete with Elon Musk's Starlink.
The Pentagon said in a statement Thursday that it has “officially informed Anthropic leadership the company and its products are deemed a supply chain risk, effective immediately.”
Opioid overdose deaths in Canada are falling, but there's growing concerns on a certain veterinary tranquilizer being cut into fentanyl and other opioids.
The product is being recalled in Alberta, British Columbia, Manitoba, Ontario, Quebec and Saskatchewan due to 'undeclared almonds' being found.
Toronto Maple Leafs defenceman Chris Tanev is out for the rest of the season, the NHL team announced Wednesday.
A large swath of southern Alberta is under a snowfall warning, with up to 30 centimetres of snow forecast to fall in some areas before the snow tapers off by Saturday morning.
Coined forever chemicals due to the years it takes for them to break down, PFAS are 'a group of thousands of human-made chemicals' commonly found in everyday items.